428 related articles for article (PubMed ID: 29055182)
41. PhenoDis: a comprehensive database for phenotypic characterization of rare cardiac diseases.
Adler A; Kirchmeier P; Reinhard J; Brauner B; Dunger I; Fobo G; Frishman G; Montrone C; Mewes HW; Arnold M; Ruepp A
Orphanet J Rare Dis; 2018 Jan; 13(1):22. PubMed ID: 29370821
[TBL] [Abstract][Full Text] [Related]
42. A computational drug repositioning method applied to rare diseases: Adrenocortical carcinoma.
Lotfi Shahreza M; Ghadiri N; Green JR
Sci Rep; 2020 Jun; 10(1):8846. PubMed ID: 32483162
[TBL] [Abstract][Full Text] [Related]
43. HGV2011: personalized genomic medicine meets the incidentalome.
Wilson Sayres MA; Brookes AJ; Chanock SJ; Cheung VG; Goldstein DB; Jin L; Kwok PY
Hum Mutat; 2012 Mar; 33(3):582-5. PubMed ID: 22170622
[TBL] [Abstract][Full Text] [Related]
44. Drug Repurposing for Rare Diseases.
Roessler HI; Knoers NVAM; van Haelst MM; van Haaften G
Trends Pharmacol Sci; 2021 Apr; 42(4):255-267. PubMed ID: 33563480
[TBL] [Abstract][Full Text] [Related]
45. Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks.
Liu H; Song Y; Guan J; Luo L; Zhuang Z
BMC Bioinformatics; 2016 Dec; 17(Suppl 17):539. PubMed ID: 28155639
[TBL] [Abstract][Full Text] [Related]
46. Identification of Repurpose Drugs by Computational Analysis of Disease-Gene-Drug Associations.
Gopal J; Prakash Sinnarasan VS; Venkatesan A
J Comput Biol; 2021 Oct; 28(10):975-984. PubMed ID: 34242526
[TBL] [Abstract][Full Text] [Related]
47. Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning.
Wang R; Li S; Cheng L; Wong MH; Leung KS
BMC Bioinformatics; 2019 Dec; 20(Suppl 26):628. PubMed ID: 31839008
[TBL] [Abstract][Full Text] [Related]
48. Use of genome editing tools in human stem cell-based disease modeling and precision medicine.
Wei YD; Li S; Liu GG; Zhang YX; Ding QR
Yi Chuan; 2015 Oct; 37(10):983-91. PubMed ID: 26496750
[TBL] [Abstract][Full Text] [Related]
49. Towards precision medicine-based therapies for glioblastoma: interrogating human disease genomics and mouse phenotypes.
Chen Y; Gao Z; Wang B; Xu R
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):516. PubMed ID: 27557118
[TBL] [Abstract][Full Text] [Related]
50. Systems biology based drug repositioning for development of cancer therapy.
Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
[TBL] [Abstract][Full Text] [Related]
51. Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data.
Pulley JM; Rhoads JP; Jerome RN; Challa AP; Erreger KB; Joly MM; Lavieri RR; Perry KE; Zaleski NM; Shirey-Rice JK; Aronoff DM
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():333-352. PubMed ID: 31337270
[TBL] [Abstract][Full Text] [Related]
52. Use of Computational Functional Genomics in Drug Discovery and Repurposing for Analgesic Indications.
Lötsch J; Kringel D
Clin Pharmacol Ther; 2018 Jun; 103(6):975-978. PubMed ID: 29350398
[TBL] [Abstract][Full Text] [Related]
53. Genomic Medicine in Primary Care.
Hajek C
S D Med; 2017 Spec; Spec No():62-65. PubMed ID: 28817866
[TBL] [Abstract][Full Text] [Related]
54. Network-based drug ranking and repositioning with respect to DrugBank therapeutic categories.
Re M; Valentini G
IEEE/ACM Trans Comput Biol Bioinform; 2013; 10(6):1359-71. PubMed ID: 24407295
[TBL] [Abstract][Full Text] [Related]
55. Computational drug repositioning for cancer therapeutics.
Jiao M; Liu G; Xue Y; Ding C
Curr Top Med Chem; 2015; 15(8):767-75. PubMed ID: 25732789
[TBL] [Abstract][Full Text] [Related]
56. Turning omics data into therapeutic insights.
Kedaigle A; Fraenkel E
Curr Opin Pharmacol; 2018 Oct; 42():95-101. PubMed ID: 30149217
[TBL] [Abstract][Full Text] [Related]
57. Computational functional genomics-based approaches in analgesic drug discovery and repurposing.
Lippmann C; Kringel D; Ultsch A; Lötsch J
Pharmacogenomics; 2018 Jun; 19(9):783-797. PubMed ID: 29792109
[TBL] [Abstract][Full Text] [Related]
58. Systems Bioinformatics: increasing precision of computational diagnostics and therapeutics through network-based approaches.
Oulas A; Minadakis G; Zachariou M; Sokratous K; Bourdakou MM; Spyrou GM
Brief Bioinform; 2019 May; 20(3):806-824. PubMed ID: 29186305
[TBL] [Abstract][Full Text] [Related]
59. Drug repurposing in rare diseases: Myths and reality.
Fetro C; Scherman D
Therapie; 2020 Apr; 75(2):157-160. PubMed ID: 32241561
[TBL] [Abstract][Full Text] [Related]
60. Opportunities in systems biology to discover mechanisms and repurpose drugs for CNS diseases.
Mei H; Xia T; Feng G; Zhu J; Lin SM; Qiu Y
Drug Discov Today; 2012 Nov; 17(21-22):1208-16. PubMed ID: 22750722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
